CATARACTSCREENER CT - S

K972440 · Neitz Instruments Company, Ltd. · HKI · Sep 30, 1997 · Ophthalmic

Device Facts

• Record ID: K972440
• Device Name: CATARACTSCREENER CT - S
• Applicant: Neitz Instruments Company, Ltd.
• Product Code: HKI · Ophthalmic
• Decision Date: Sep 30, 1997
• Decision: SESE
• Submission Type: Traditional
• Regulation: 21 CFR 886.1120
• Device Class: Class 2

Intended Use

Cataractscreener CT-S is designed to observe lens opacity of human eye by retroillumination method.

Device Story

The Neitz Cataract Screener CT-S is an ophthalmic diagnostic device used to visualize lens opacities. It utilizes the retroillumination principle, where light is directed into the eye to illuminate the lens against the background of the fundus, allowing for the detection of cataracts. The device is intended for use by eye care professionals in a clinical setting. By providing a clear view of lens opacities, the device assists clinicians in the screening and assessment of cataract development, facilitating informed clinical decision-making regarding patient eye health and potential surgical intervention.

Clinical Evidence

No clinical data provided; bench testing only.

Technological Characteristics

The device utilizes the retroillumination optical principle to observe lens opacity. It is a specialized ophthalmic instrument designed for clinical use. No specific materials, connectivity, or software algorithms are detailed in the provided documentation.

Indications for Use

Indicated for the observation of lens opacity in the human eye using the retroillumination method.

Regulatory Classification

Identification

An ophthalmic camera is an AC-powered device intended to take photographs of the eye and the surrounding area.

Special Controls

*Classification.* Class II (special controls). The device, when it is a photorefractor or a general-use ophthalmic camera, is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 886.9.

Submission Summary (Full Text)

{0}------------------------------------------------

Image /page/0/Picture/1 description: The image is a black and white logo for the U.S. Department of Health & Human Services. The logo features a stylized eagle with its wings spread, and the words "DEPARTMENT OF HEALTH & HUMAN SERVICES • USA" are arranged in a circular pattern around the eagle. The eagle is composed of three thick, curved lines that suggest the shape of the bird's body and wings. The text is in a simple, sans-serif font and is evenly spaced around the circle.

SEP 3 0 1997

Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850

Mr. Masao Sugasawa Director for Sales and Marketing Neitz Instruments Co., Ltd. 36-13 Wakamatsu-Cho Shinjuku-Ka, Tokyo 162 Japan

Re: K972440 Trade Name: Neitz Cataract Screener CT - S Regulatory Class: II Product Code: 86 HKI Dated: August 15, 1997 Received: August 20, 1997

Dear Mr. Sugasawa:

We have reviewed your Section 510(k) notification of intent to market the device referenced above and we have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.

If your device is classified (see above) into either class II (Special Controls) or class III (Premarket Approval), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 895. A substantially equivalent determination assumes compliance with the Current Good Manufacturing Practice requirements, as set forth in the Quality System Regulation (QS) for Medical Devices: General regulation (21 CFR Part 820) and that, through periodic QS inspections, the Food and Drug Administration (FDA) will verify such assumptions. Failure to comply with the GMP regulation may result in regulatory action. In addition, FDA may publish further announcements concerning your device in the Federal Register. Please note: this response to your premarket notification submission does not affect any obligation you might have under sections 531 through 542 of the Act for devices under the Electronic Product Radiation Control provisions, or other Federal laws or regulations.

{1}------------------------------------------------

Page 2 - Mr. Masao Sugasawa

This letter will allow you to begin marketing your device as described in your 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.

If you desire specific advice for your device on our labeling regulation (21 CFR Part 801 and additionally 809.10 for in vitro diagnostic devices), please contact the Office of Compliance at [phone]. Additionally, for questions on.the.promotion and advertising of your device, please contact the Office of Compliance at [phone]. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR 807.97). Other general information on your responsibilities under the Act may be obtained from the Division of Small Manufacturers Assistance at its toll-free number [phone] or [phone] or at its internet address "http://www.fda.gov/cdrh/dsmamain.html".

Sincerely yours,

ARalph Rosenthal

A. Ralph Rosenthal, M.D. Director Division of Ophthalmic Devices Office of Device Evaluation Center for Devices and Radiological Health

Enclosure

{2}------------------------------------------------

Page

K 9 7 2 4 4 0 510(k) Number (if known):_____________________________________________________________________________________________________________________________________________________

Device Name: CATARACTSCREENER CT-S

Indications For Use:

4

: 2017年: 2017年 10月 10:00:00 10:00 10:00 10:00 10:00 10:00 10:00 10:00 10:00 10:00 10:00 10:00 10:00 10:00 10:00 10:00 10:00 10:00 10:00 10:00 10:00 10:00 10:00 10:00 10:00 1

ﺗﺮ ﺗ Cataractscreener CT-S is designed to observe lens opacity of human eye by retroillumination method.

(PLEASE DO NOT WRITE: BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)

Concurrence of CDRH, Office of Device Evaluation (ODE)

AmWillia

(Division Sign-Off)
Division of Ophthalmic Devices
510(k) Number. K972440

Prescription Use (Per 21 CFR 801.109) OR

Over-The-Counter Use \/

(Optional Format 1-2-96)

।